ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
The Impact of Institutional Volume on Transcatheter Aortic Valve Replacement Outcomes.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prior studies have demonstrated a consistent association between higher institutional procedural volume and improved clinical outcomes. To evaluate the relationship between institutional transcatheter aortic valve replacement (TAVR) volume and key patient outcomes, and to identify which metrics are most sensitive to volume variation. We analyzed 91,494 non-impella-assisted TAVR procedures performed at 118 US hospitals using the Vizient Clinical Data Base (28,077 in 2022; 30,602 in 2023; 32,815 in 2024). Annual case volume categories (e.g., 1-100 through 801-900) were used to stratify institutions. Key outcomes-including mean length of stay (LOS), early mortality, mean ICU stay, and observed mortality-were compared across volume groups using ANOVA and ANCOVA to adjust for case mix index (CMI). Higher institutional TAVR volume was significantly associated with shorter mean LOS in 2022 (ANOVA p = 0.0007; ANCOVA p < 0.0001), 2023 (ANOVA p = 0.0016; ANCOVA p = 0.0003), and 2024 (ANOVA p < 0.0001; ANCOVA p < 0.0001). In 2023, higher volume was associated with significantly lower early mortality (ANOVA p = 0.0195; ANCOVA p = 0.0165). In 2024, higher volume correlated with significantly lower overall observed mortality (ANOVA p = 0.0004; ANCOVA p < 0.0001). No significant associations were found between volume and mean ICU stay in any year. Higher institutional TAVR volume is independently associated with improved outcomes, including reduced LOS, early mortality, and overall observed mortality. These associations persist after adjustment for CMI, suggesting intrinsic differences in care delivery across volume strata.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.